1. Aghion P, Howitt P (1992) A model of growth through creative destruction. Econometrica 60(2):323–351
2. Blackstone EA (2013) Fuhr JP (2013) The Economics of Biosimilars. Am Health Drug Benefits. 6(8):469–478
3. Pharma Boardroom (2019) Legal & Regulatory > Denmark > Regulatory, Pricing and Reimbursement
4. de Chaisemartin C, D’Haultfœuille X, Guyonvarch Y (2021) DID_MULTIPLEGT: Stata module to estimate sharp Difference-in-Difference designs with multiple groups and periods. Statistical Software Components S458643, Boston College Department of Economics, revised 03 Jan 2021
5. Chen Y, Riordan MH (2008) Price-Increasing Competition. RAND J Econ 39(4):1042–1058 (Winter)